Nurix Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts that cover Nurix Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $30.5, which forecasts a 78.57% increase in the stock price over the next year. The lowest target is $26 and the highest is $36.

Price Target: $30.5 (+78.57%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$26	$30.5	$30	$36
Change	+52.22%	+78.57%	+75.64%	+110.77%

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	6	6	6	6	6	6
Buy	6	5	7	7	6	6
Hold	2	2	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	13	14	14	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $32	Strong Buy	Reiterates	$32	+87.35%	Apr 27, 2026
Gil Blum Needham	Needham	Strong Buy Reiterates $26	Strong Buy	Reiterates	$26	+52.22%	Apr 23, 2026
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $32	Strong Buy	Reiterates	$32	+87.35%	Apr 10, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $29 → $28	Buy	Maintains	$29 → $28	+63.93%	Apr 9, 2026
Gil Blum Needham	Needham	Strong Buy Reiterates $26	Strong Buy	Reiterates	$26	+52.22%	Apr 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

57.30M

from 83.98M

-31.77%

from 83.98M

Revenue Next Year

84.83M

from 57.30M

48.05%

from 57.30M

EPS This Year

-3.11

from -3.05

EPS Next Year

-2.99

from -3.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Nov 30, 2021	Nov 30, 2022	Nov 30, 2023	Nov 30, 2024	Nov 30, 2025	Nov 30, 2026	Nov 30, 2027
Revenue	29.75M	38.63M	76.99M	54.55M	83.98M	57.30M	84.83M
Revenue Growth	66.95%	29.84%	99.31%	-29.15%	53.95%	-31.77%	48.05%
EPS	-2.73	-3.71	-2.65	-2.88	-3.05	-3.11	-2.99
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	99.8M	228.1M
Avg	57.3M	84.8M
Low	39.5M	41.5M

Revenue Growth

Revenue Growth	2026	2027
High	18.8%	298.0%
Avg	-31.8%	48.1%
Low	-52.9%	-27.5%

EPS Forecast

EPS	2026	2027
High	-2.69	-2.17
Avg	-3.11	-2.99
Low	-3.64	-3.34

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.